Leiomyoma of uterus, unspecified
ICD-10 D25.9 is a billable code used to indicate a diagnosis of leiomyoma of uterus, unspecified.
Leiomyomas, commonly known as uterine fibroids, are benign tumors that arise from the smooth muscle tissue of the uterus. They can vary in size, number, and location within the uterus, and while many women may experience no symptoms, others may suffer from significant complications. Symptoms can include heavy menstrual bleeding, pelvic pain, pressure symptoms, and reproductive issues such as infertility or pregnancy complications. The exact cause of leiomyomas is not fully understood, but they are believed to be influenced by hormonal factors, particularly estrogen and progesterone. Diagnosis typically involves imaging studies such as ultrasound or MRI, and treatment options range from watchful waiting to medical management with hormonal therapies, or surgical interventions such as myomectomy or hysterectomy, depending on the severity of symptoms and the patient's reproductive plans. The unspecified nature of this code indicates that the specific type, size, or location of the leiomyoma is not documented, which can complicate treatment planning and management.
Detailed documentation of symptoms, imaging results, and treatment plans is essential.
Patients presenting with heavy menstrual bleeding or pelvic pain requiring evaluation.
Consideration of the patient's reproductive plans is crucial for treatment decisions.
Clear imaging reports indicating the size, location, and characteristics of the leiomyoma.
Ultrasound or MRI evaluations for suspected uterine fibroids.
Accurate imaging interpretation is vital for guiding treatment options.
Used when a patient with D25.9 undergoes a hysterectomy due to symptomatic fibroids.
Operative report detailing the indication for surgery and findings.
Obstetricians should document the patient's history and symptomatology leading to surgery.
D25.9 is used when the specific type of leiomyoma is not documented. Other D25 codes specify the location or type of the fibroid, which can impact treatment options.
Yes, D25.9 can be used for patients with symptoms, but it is important to document the symptoms and any relevant imaging findings to support the diagnosis.
